PRIVILEGED INFORMATION DISCLOSURE

TRANSACTION DISCLOSURE

“DIAGNOSTIC AND THERAPEUTIC CENTER OF ATHENS HYGEIA SA” (hereinafter the “Issuer”) announces that, pursuant to Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 and Commission Implementing Regulation (EU) 2016/1055 of 29 June 2016, on 27 October 2016, shareholder “MARFIN INVESTMENT GROUP HOLDINGS S.A.”, a person who can be considered as being closely associated with individuals who exercise managerial duties at the Issuer, namely Mr. Andreas Vgenopoulos (Non-Executive Board Chairman) and Mr. Georgios Efstratiadis (Non-Executive Board Member), notified the Hellenic Capital Market Commission and the Issuer of the following:

-  On 24/10/2016 the pledged in favor of “EUROBANK ERGASIAS SA” on 54,838,932 issuer shares, owned by the aforementioned shareholder, was lifted. On 24/10/2016, the closing price of the share amounted to €0.153.

- On 25/10/2016, 54,838,932 and 45,326,574 (i.e. 100,165,506 in total) Issuer shares, owned by the aforementioned shareholder, were pledged in favor of “EUROBANK ERGASIAS SA”. On 25/10/2016, the closing price of the share amounted to €0.152.